BP-001

BP-001 is a pediatric oral formulation of an antibiotic developed by Brillian Pharma using its proprietary Unidose delivery technology. The product is designed as either an oral solution or a lyophilized powder for reconstitution, specifically tailored to improve dosing precision and ease of administration for children. Brillian Pharma's business model focuses on the reformulation of established therapeutic agents into child-friendly formats rather than the discovery of new molecular entities. BP-001 is intended for the treatment of various pediatric bacterial infections, leveraging the established efficacy and safety profile of the underlying antibiotic while enhancing its delivery for the pediatric population.